Tafalgie Therapeutics
PrivateLast Round
Series A
Sep 15, 2025
Total Funding Raised
$16.82M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Tafalgie Therapeutics is a biotechnology company that develops non-opioid, pain-relieving peptide therapeutics for the treatment of acute and chronic pain.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tafalgie Therapeutics Comparables
Compare Tafalgie Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Latigo Biotherapeutics | 81% | |
| Akelos Inc. | 80% | |
| Algiax Pharmaceuticals | 80% |
Tafalgie Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 15, 2025 | ||||
| Grant | Nov 1, 2023 |
Tafalgie Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 72% MoM.
- Apr 6, 2026
Monthly visitors increased 38% MoM, reaching 1.2K.
Tafalgie Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Tafalgie Therapeutics's valuation, stock price, and market status.
Is Tafalgie Therapeutics a public or private company?
Tafalgie Therapeutics is a private company.
What is the current stock price of Tafalgie Therapeutics?
Tafalgie Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Tafalgie Therapeutics worth (valuation)?
Valuation information for Tafalgie Therapeutics is not publicly available.
Can I buy Tafalgie Therapeutics stock?
Tafalgie Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Tafalgie Therapeutics's last funding round?
Tafalgie Therapeutics's most recent funding round was Series A on September 15, 2025.
Who are the main investors in Tafalgie Therapeutics?
Key investors in Tafalgie Therapeutics include European Innovation Council.
Will Tafalgie Therapeutics IPO soon?
No public IPO plans have been announced for Tafalgie Therapeutics.
How can I track Tafalgie Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Tafalgie Therapeutics's secondary market activity and sign up for updates.